Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
about
Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodentsMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathwayDUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibilityJun kinase delays caspase-9 activation by interaction with the apoptosomeForced expression of the cell cycle inhibitor p57Kip2 in cardiomyocytes attenuates ischemia-reperfusion injury in the mouse heart.RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.TRPC channels are necessary mediators of pathologic cardiac hypertrophy.Post-conditioning protecting rat cardiomyocytes from apoptosis via attenuating calcium-sensing receptor-induced endo(sarco)plasmic reticulum stress.c-Jun N-terminal kinase phosphorylation of stathmin confers protection against cellular stressCrosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesMyocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.Inhibition of JNK aggravates the recovery of rat hearts after global ischemia: the role of mitochondrial JNK.c-Jun N-terminal kinase (JNK-1) confers protection against brief but not extended ischemia during acute myocardial infarction.Mechanisms underlying acute protection from cardiac ischemia-reperfusion injuryRole of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart TransplantationUpdate on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic MyocardiumNemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart.Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.The virtue of just enough stress: a molecular model.Role of xanthine oxidoreductase in cardiac nitroso-redox imbalanceInhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats.Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6.Ischemic preconditioning in solid organ transplantation: from experimental to clinics.Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injuryStromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia.Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathwayMitogen-activated protein kinases in heart development and diseasesc-Jun N-terminal kinases as potential therapeutic targets.DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling.Inducible and myocyte-specific inhibition of PKCalpha enhances cardiac contractility and protects against infarction-induced heart failure.Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repairGenetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling.Cdc42 is an antihypertrophic molecular switch in the mouse heart.Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation.ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic miceFoxO transcription factors promote autophagy in cardiomyocytesCell biology of ischemia/reperfusion injury.Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury.
P2860
Q24321617-E9771A4A-51C7-4B72-A6AC-8A5217BA26F5Q28296128-E447509F-B394-4101-B6DB-C70A6254313AQ28505975-B3163733-2739-4EC4-BA15-B0C1F0BA732EQ28511686-2F57E3C1-9619-4B86-B006-CE711DF9D850Q28580043-2B4BD143-EF0D-488B-BE30-7C012C8BBB55Q33321972-A2AD2AD8-EBC2-4DFC-86F6-0542A231CA63Q33559727-04B78F00-8B33-4848-B191-42329E4014ABQ33859656-DCDEF85E-A117-4AB8-8EAA-4D2433A5C725Q34044534-AD369D79-6615-49DB-BC3F-A6258A15E5BBQ34121410-236663C2-C2AB-46E0-A34F-B40DC9FD321FQ34289211-8207D576-9087-4FA3-9709-74A6D7A60455Q34380219-B3A5C264-BE43-47A2-B8D8-FA9887D62E99Q34571926-8FC3963B-2C21-4EA0-91F3-62C4B92FC52DQ34799991-CDF12D16-832B-4323-8209-5AED1C3474DFQ35424798-6A87371E-3D6B-4455-94C2-38CA225E87E3Q35864123-E4876C5E-7B50-40C4-AA99-5334E59764FBQ36055827-440DD32E-E6F1-48E9-AD4C-E90BEE43F7C3Q36169194-A7F0008D-76EB-4BD6-88FA-D642E8124508Q36478411-EBF61497-2DDB-4F08-B02D-5113CF617F87Q36519710-9CA21B92-0DD8-43A3-8C2E-C4D7D37A7B93Q36557850-C5E095B8-CB8F-4D1A-A427-AFFD23F72C82Q36596206-4883838C-6D68-44B8-B496-6004F8F83253Q36620448-98156A94-5FD8-4917-9690-6E52DF15E4E6Q36732584-E02E93F7-61F9-4909-920D-3EF5FD05BDABQ36795745-DC0ECB9C-8A4F-4482-A28D-A4E795B4ECFEQ36806897-73EDEB0C-B466-4DCC-AEB1-64DAD25B230EQ36820646-032B857B-A688-4CC6-98AB-1A5DE01586EAQ36889171-617F6F84-A99C-40EB-8D55-DCE563DF1B5EQ36944485-7EFCED51-AD88-410C-9017-19923F89D0C0Q36956736-23CB27A1-A798-4108-B05B-14B5DE39FDDCQ37079744-56AE4A0E-5E59-4C18-B3E0-09E2CE8E9A83Q37101607-936FCCBD-6562-40C9-AAF0-926CCBFC8666Q37101612-58B940F2-84D1-49BE-B65F-6DD814D68887Q37187381-292892A4-7DA5-4B58-B694-FF70C1C008D8Q37363031-EE12A9D3-5549-4ACD-9EF5-725374683C4EQ37398277-3783C724-C791-48D8-94F7-9DA2F3A215B2Q37437991-97E597CE-CF11-4AA4-8BCB-13D290682EBDQ37459990-A9F465BD-DEFB-44BA-8AE4-1AECF9B6F34AQ37524901-3EF18FAD-238C-4AAC-A9F7-06D02B59AF2FQ37674817-E517A79E-D118-4637-9993-FAB494C577C8
P2860
Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Genetic inhibition or activati ...... on-induced cell death in vivo.
@en
Genetic inhibition or activati ...... on-induced cell death in vivo.
@nl
type
label
Genetic inhibition or activati ...... on-induced cell death in vivo.
@en
Genetic inhibition or activati ...... on-induced cell death in vivo.
@nl
prefLabel
Genetic inhibition or activati ...... on-induced cell death in vivo.
@en
Genetic inhibition or activati ...... on-induced cell death in vivo.
@nl
P2093
P2860
P356
P1476
Genetic inhibition or activati ...... on-induced cell death in vivo.
@en
P2093
Orlando Bueno
Qiangrong Liang
Raisa Klevitsky
Robert A Kaiser
Timothy E Hewett
Troy Lackey
Yuan Huang
P2860
P304
32602-32608
P356
10.1074/JBC.M500684200
P407
P577
2005-07-25T00:00:00Z